Background：Cytokeratin 8 （CK8） has a molecular weight of 52.5 KDa, which belongs to the HMW （high molecular weight） B-type Cytokeratin. CK8 is mainly marked on non-squamous epithelium, thus can be used for the diagnosis of adenocarcinoma and ductal carcinoma. Generally, CK8 is not expressed in squamous cell carcinoma. It is reported that hepatocellular carcinoma mainly express CK8 and CK18.
仕様
Synonyms：CARD2,CK 8,CK-8,CK8,CYK8,CYKER,Cytokeratin endo A,Cytokeratin-8,DreK8,EndoA,K2C8,K2C8,K8,Keratin 8,Keratin type II cytoskeletal 8,Keratin,type II cytoskeletal 8,Keratin-8,KO,Krt 2.8,KRT8,MGC118110,MGC174782,MGC53564,MGC85764,sb：cb186,Type-II keratin Kb8
Host：Rabbit
Reactivity：Human,Mouse,Rat
Applications：WB,IHC-p,IF,ELISA
Concentration：1mg/mL
Immunogen：Synthesized peptide derived from human Cytokeratin 8 around the phosphorylation site of S432.
Purification Method：Affinity purification
Clonality：Polyclonal
Conjugation：Unconjugated
Buffer：PBS with 0.02％ sodium azide,0.5％ BSA and 50％ glycerol pH 7.4.
Dilution：WB 1：500-1：2000, IHC 1：100-1：300, IF 1：200-1：1000, ELISA 1：40000
